Image: Richard Townshend [CC BY 3.0], via Wikimedia Commons
Party sets out life sciences goals, including long-term public R&D funding to encourage private investment
Labour has laid out its ideas for growing the UK life sciences sector, aiming for an annual increase in pharmaceutical research and development investment of £10 billion by 2028.
Proposals to “turbocharge” UK pharmaceutical R&D rest in part on “taking a long-term approach to public R&D funding” to encourage private sector investment.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.